| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/31/2006 | CN1257740C Preparation of pure Chinese traditional medicine for curing acute nephritis and chronic nephritis |
| 05/31/2006 | CN1257737C Chinese traditional medicinal composition for treating hemicrania and its preparing process |
| 05/31/2006 | CN1257735C Medicine for treating heart function insufficieny and preparing method thereof |
| 05/31/2006 | CN1257734C Tangnaikang granule and its preparing process |
| 05/31/2006 | CN1257732C Medicine for treating mastosis and preparation process thereof |
| 05/31/2006 | CN1257731C Pollen and medicinal composition for cosmetics and its preparation |
| 05/31/2006 | CN1257730C Medicine for treating oligospermia and preparing process thereof |
| 05/31/2006 | CN1257729C Medicine for treating headache and preparing method thereof |
| 05/31/2006 | CN1257728C Ready made traditional Chinese medicine for treating diabetes and its preparation method |
| 05/31/2006 | CN1257724C Composition for preventing and treating diabets mellitus |
| 05/31/2006 | CN1257723C Powder injection for intravenous injection and its preparing method |
| 05/31/2006 | CN1257720C Capsule of Chinese traditional medicine for treating thrombus |
| 05/31/2006 | CN1257717C Medicine for treating pertinacious porking diarrhea and its preparation method |
| 05/31/2006 | CN1257715C Clindamycin metronidazole vagina effervescent tablet and its preparing method and use |
| 05/31/2006 | CN1257714C Injection of liposome of daunorubicin or hydrochloric daunorubicin and preparation method |
| 05/31/2006 | CN1257713C Flunarizine hydrochloride injection and its preparing method |
| 05/31/2006 | CN1257711C Butyl benzene phthalein soft capsule and its preparation method |
| 05/31/2006 | CN1257710C Preparation made from effective position of red sage root, and its preparation method |
| 05/31/2006 | CN1257709C Tensicor freeze-drying formulation and its making method |
| 05/31/2006 | CN1257708C Modified water-soluble medicine and vaccine embedded macromolecule microsphere preparation method |
| 05/31/2006 | CN1257680C Gargling tooth-cleaning chewing gum |
| 05/30/2006 | US7053209 sustained release; may be diluted with solvent for administration |
| 05/30/2006 | US7053192 Crystal forms of azithromycin |
| 05/30/2006 | US7053121 Phase-shifting by modulating a retinoid nuclear receptor |
| 05/30/2006 | US7053069 Pharmaceutical compositions and methods of using C-21 modified epothilone derivatives |
| 05/30/2006 | US7053068 Chitosan-thio-amidine conjugates and their cosmetic as well as pharmaceutic use |
| 05/30/2006 | US7053061 Vegetable oil phase containing dispersed Amphotercin B; water phase containing dissolved glycerin, mannitol, or dextrose tonicity modifiers; emulsifier such as natural phosphatides |
| 05/30/2006 | US7053059 Dialysis solutions with reduced levels of glucose degradation products |
| 05/30/2006 | US7053054 Purified LH |
| 05/30/2006 | US7053034 Targeted controlled delivery compositions activated by changes in pH or salt concentration |
| 05/30/2006 | US7052913 capsules comprising biocompatible silica sol-gel matrices that encapsulate chemical intermediates or prodrugs that convert when contacted with tissues and/or fluids; grafting encapsulated L-amino acid decarboxylase in the brain to convert L-dopa to dopamine for prophylaxis of Parkinson's disease |
| 05/30/2006 | US7052832 Determining sensitivity of a cell to reovirus infection; obtain cells, monitor ras protein signaling, consistent signaling indicates sensitivity to reovirus infection |
| 05/30/2006 | US7052719 Matrices formed of polymer and hydrophobic compounds for use in drug delivery |
| 05/30/2006 | US7052718 Dispersing ability, dispersing stability, water repellency and feel |
| 05/30/2006 | US7052717 Storage stable thyroxine active drug formulations and methods for their production |
| 05/30/2006 | US7052716 Cosmetic and dermatological preparations comprising an effective content of bile acids, their salts and/or their derivatives |
| 05/30/2006 | US7052715 Alcohol-free transdermal analgesic composition and processes for manufacture and use thereof |
| 05/30/2006 | US7052714 Ophthalmic adhesive preparations for percutaneous adsorption |
| 05/30/2006 | US7052713 elastic biodegradable collagen from mammalian, transgenic or recombinant sources; for surgical interventions on the liver, spleen, pancreas, kidneys, lungs, adrenal glands, thyroid and lymph nodes; hemostasis, tissue sealing and tissue gluing; free of antifibronolytic agents |
| 05/30/2006 | US7052712 Animal feeds including actives and methods of preparing same |
| 05/30/2006 | US7052711 Nitric oxide-producing hydrogel materials |
| 05/30/2006 | US7052706 Control release formulation containing a hydrophobic material as the sustained release agent |
| 05/30/2006 | US7052689 Preventing viral replication in cells; obtain cells, incubate with viricide, monitor cells for reduced viral activity |
| 05/30/2006 | US7052688 At least one strain of hydrogen peroxide-producing lactic acid bacteria, and at least one strain of arginine-utilizing lactic acid bacteria; treatment of infections and inflammatory conditions caused by bacteria, viruses, fungi |
| 05/30/2006 | US7052680 aerosols containing antiparkinsons drugs benzotropine, pergolide, amantadine, deprenyl and ropinerole, that have been heated on a solid support such as foil and condensed by passing through a flow of air |
| 05/30/2006 | US7052679 thin film of drugs; heating; dispensing as aerosol condensation |
| 05/30/2006 | US7052678 Particles for inhalation having sustained release properties |
| 05/30/2006 | US7052672 Stabilized radiopharmaceutical compositions |
| 05/30/2006 | US7052488 Implantable drug delivery device |
| 05/30/2006 | US7052275 Kits and methods for bleaching and desensitizing teeth |
| 05/30/2006 | CA2391659C Crystal forms of azithromycin |
| 05/30/2006 | CA2288970C Use of microparticles having a protein and an antibody adsorbed thereon for preparing a pharmaceutical composition for intranasal administration |
| 05/30/2006 | CA2264718C Solid coprecipitates for enhanced bioavailability of lipophilic substances |
| 05/30/2006 | CA2260637C Free-flowable, directly compressible starch as binder, distinegrant and filler for compression tablets and hard gelatine capsules |
| 05/30/2006 | CA2258841C Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug |
| 05/30/2006 | CA2217226C Controlled release formulation for water soluble drugs in which a passageway is formed in situ |
| 05/30/2006 | CA2181715C Liquid ophthalmic sustained release delivery system |
| 05/26/2006 | WO2006055950A1 Pharmaceutical dry powder formulation on the basis particles comprising multiple active agents |
| 05/26/2006 | WO2006055903A1 Method for loading multiple agents into delivery vehicles |
| 05/26/2006 | WO2006055742A1 Enteric coated bead comprising epothilone or epothilone analog, and preparation and administration thereof |
| 05/26/2006 | WO2006055740A1 Enteric coated bead comprising ixabepilone, and preparation thereof |
| 05/26/2006 | WO2006055632A2 Pharmaceutical manufacturing process for heat sterilized glucocorticoid suspensions |
| 05/26/2006 | WO2006055532A2 Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof |
| 05/26/2006 | WO2006055511A2 Stable tablet formulation of tetrahydrobiopterin |
| 05/26/2006 | WO2006055447A2 Nanoparticles having a magnetic core and a cationic organo-silane coating for the delivery of oligonucleotides |
| 05/26/2006 | WO2006055352A2 Methods of treating cancer with lipid-based platinum compound formulations administered intraperitoneally |
| 05/26/2006 | WO2006055142A2 Taste-masked multiparticulate pharmaceutical compositions comprising a drug-containing core particle and a solvent-coacervated membrane |
| 05/26/2006 | WO2006055008A2 Implantable sensors and implantable pumps and anti-scarring agents |
| 05/26/2006 | WO2006054589A1 Medicinal composition, medicinal preparation, and combination preparation |
| 05/26/2006 | WO2006054315A1 Nonaqueous liquid parenteral aceclofenac formulation |
| 05/26/2006 | WO2006054308A2 Stable atorvastatin formulations |
| 05/26/2006 | WO2006054307A2 Controlled absorption of statins in the intestine |
| 05/26/2006 | WO2006054175A2 Stable dosage forms of acid labile drug |
| 05/26/2006 | WO2006054165A1 Pharmaceutical compositions of alendronic acid and processes for their preparation |
| 05/26/2006 | WO2006054152A1 Monocompartment osmotic-controlled delivery system of doxazosin |
| 05/26/2006 | WO2006053836A1 Active substance delivery system comprising a hydrogel atrix and microcarriers |
| 05/26/2006 | WO2006053760A1 Pharmaceutical compositions comprising (+) - (2s, 3s) - 2 - (chlorophenyl) - 3, 5, 5-trimethhyl-2-morpholinol |
| 05/26/2006 | WO2006053755A1 Pharmaceutical compositions comprising a camtothecin derivate |
| 05/26/2006 | WO2006053712A2 Process and device for producing finely divided liquid-liquid formulations, and the uses of these liquid-liquid formulations |
| 05/26/2006 | WO2006053646A2 Improvements in or relating to pharmaceutical compositions for local administration |
| 05/26/2006 | WO2006053604A1 Production of double- or multi-layered microcapsules |
| 05/26/2006 | WO2006053564A2 Stabilisation of granules comprising active compounds |
| 05/26/2006 | WO2006053430A1 Sirna silencing of apolipoprotein b |
| 05/26/2006 | WO2006037070A3 Stabilization of alum-adjuvanted immunologically active agents |
| 05/26/2006 | WO2006028830A3 Opioid dosage forms having dose proportional steady state cave and auc and less than dose proportional single dose cmax |
| 05/26/2006 | WO2006024881A3 Multiparticulates of preferably an opioid, and method of manufacturing using extrusion |
| 05/26/2006 | WO2006021426A3 Psychostimulant containing pharmaceutical composition |
| 05/26/2006 | WO2006020739A3 Compositions and methods for nutrition supplementation |
| 05/26/2006 | WO2006015590A3 Novel formulation for l-tryptophane comprising carbidopa/benserazide |
| 05/26/2006 | WO2006008173A3 Pharmaceutical formulations for inhalation |
| 05/26/2006 | WO2006007881A3 New pharmaceutical compositions based on fluorenecarboxyclic acid esters and soluble tnf receptor fusion proteins |
| 05/26/2006 | WO2006004588A3 Immunodynamic complexes and methods for using and preparing such complexes |
| 05/26/2006 | WO2005120435A3 Method for preparing sustained release compositions and the use of said compositions for treating chronic diseases of central nervous system (cns) |
| 05/26/2006 | WO2005115339A3 Composition for enhancing absorption of a drug and method |
| 05/26/2006 | WO2005098429A3 System and method for real-time diagnosis, treatment, and therapeutic drug monitoring |
| 05/26/2006 | WO2005082336A3 Kit comprising a plaster that optionally contains an active ingredient and an agent that prevents skin irritation |
| 05/26/2006 | WO2005081743A3 Membrane scaffold proteins |
| 05/26/2006 | WO2005070134A3 Iontophoretic devices and methods |
| 05/26/2006 | WO2005063210A3 Loading of a camptothecin drug into colloidal nanoparticles |
| 05/26/2006 | WO2005055993A3 Pharmaceutical preparation containing gabapentin |